SH/EAHP 2007 Workshop - Progress in T-cell and NK cell Malignancies - title graphic

Cases by Session

Cases by Contact Submitter

Submitter Contact Information

Session 1. Chronic myelogenous leukemia

Session Chair Presented Cases
Vardiman - Presentation Link
Presented Cases
  • 052:
Chronic myelogenous leukemia, Ph+, followed by chronic idiopathic myelofibrosis, JAK2V617F+.
  • 137:
Chronic myelogenous leukemia initially presenting with precursor T-lymphoblastic transformation in an extramedullary site.
  • 149:
Chronic myelogenous leukemia, chronic phase.
  • 160:
 Philadelphia chromosome-negative blast transformation of CML under Gleevec therapy.
  • 175:
Chronic myeloid leukemia in accelerated phase.
  • 186:
Chronic myelogenous leukemia, blast phase (precursor B lymphoblastic leukemia) with genomic amplification of BCR-ABL1.
Other Cases in the Session
  • 041:
 Chronic myelogenous leukemia, chronic phase.
  • 049:
 Philadelphia chromosome positive anaplastic large cell lymphoma, possible evolved from CML.
  • 080:
 Chronic myeloid leukemia- blast phase, presursor B-cell phenotype.
  • 090:
 Chronic myeloid leukemia in blast transformation with shifts in genetically related but distinct CML clones following sequential introduction of effective bcr-abl kinase inhibitors.
  • 092:
 Chronic myeloid leukemia with blast crisis presented with bone pain, hypercalcemia and multiple lytic bone lesions that highly mimic multiple myeloma.
  • 095:
 Chronic myelogenous leukemia with myelofibrosis presenting in myeloid blast phase.
  • 120:
 Bilineal acute leukemia, myeloid and B lymphoid, arising from a Ph + chronic myelogenous leukemia, previously not detected.
  • 134:
 Chronic myeloproliferative disorder, not otherwise specified, JAK2 V617F and BCR/ABL positive.
  • 157:
 Acute leukemia best classified as chronic myelogenous leukemia, blast phase.
  • 166:
 Chronic myeloproliferative disease with t(4;22)(q12;q11.2) and presumptive BCR-PDGFRA fusion gene.
  • 211:
 Residual disease of chronic myelogenous leukemia with variant translocation.
  • 213:
 Chronic myelogenous leukemia with variant translocation t(9;17;22)(p24;p11.1;q11.2). Presumed fusion of BCR and JAK2.
  • 216:
 Chronic myelogenous leukemia in blast phase (extramedullary).
  • 222:
 Chronic myelogenous leukemia, accelerated phase, with extensive marrow fibrosis.

Back to Top

Back to Cases by Session